ADMA (ADMA Biologics, Inc.) Stock Financials & Earnings | Market Cap Arena

ADMA (ADMA Biologics, Inc.) Stock Financials & Earnings | Market Cap Arena

ADMAADMA Biologics, Inc.

Mkt Cap$4B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$510M

Net Income (TTM)$147M

EPS (TTM)$0.60

Free Cash Flow (TTM)$28M

Gross Margin57.4%

Op. Margin37.5%

Net Margin28.8%

FCF Margin5.5%

P/S Ratio (TTM)7.5x

P/E Ratio (TTM)25.9x

YoY Rev Growth+19.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$57M	$17M	-$813K
Q2 23	$60M	$17M	-$473K
Q3 23	$67M	$25M	$9M
Q4 23	$74M	$31M	$14M
Q1 24	$82M	$39M	$22M
Q2 24	$107M	$57M	$39M
Q3 24	$120M	$60M	$40M
Q4 24	$118M	$63M	$38M
Q1 25	$115M	$61M	$35M
Q2 25	$122M	$67M	$43M
Q3 25	$134M	$76M	$51M
Q4 25	$139M	$89M	$63M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	21.0x	—
Q2 23	18.3x	—
Q3 23	16.3x	—
Q4 23	14.8x	—
Q1 24	13.5x	—
Q2 24	11.5x	109.6x
Q3 24	10.0x	55.9x
Q4 24	8.9x	19.3x
Q1 25	8.3x	18.4x
Q2 25	8.0x	18.2x
Q3 25	7.8x	18.2x
Q4 25	7.5x	25.9x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$15M	-$17M
Q2 23	-$6M	-$7M
Q3 23	$12M	$11M
Q4 23	$18M	$16M
Q1 24	-$2M	-$5M
Q2 24	$46M	$44M
Q3 24	$25M	$24M
Q4 24	$50M	$47M
Q1 25	-$20M	-$24M
Q2 25	$21M	$19M
Q3 25	$13M	-$1M
Q4 25	$36M	$35M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$2M
Q2 23	$873K
Q3 23	$757K
Q4 23	$1M
Q1 24	$2M
Q2 24	$2M
Q3 24	$1M
Q4 24	$3M
Q1 25	$5M
Q2 25	$2M
Q3 25	$14M
Q4 25	$1M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+95.6%	+31.4%
Q2 23	+77.3%	+40.7%
Q3 23	+63.7%	+16.2%
Q4 23	+47.9%	+6.5%
Q1 24	+43.9%	+4.0%
Q2 24	+78.3%	+12.2%
Q3 24	+78.1%	+36.9%
Q4 24	+59.1%	+32.8%
Q1 25	+40.2%	+33.1%
Q2 25	+13.8%	+16.5%
Q3 25	+12.0%	+3.8%
Q4 25	+18.4%	-3.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$1M	2.0%
Q2 23	$2M	2.7%
Q3 23	$2M	2.5%
Q4 23	$2M	2.4%
Q1 24	$2M	2.6%
Q2 24	$3M	2.7%
Q3 24	$3M	2.7%
Q4 24	$5M	4.6%
Q1 25	$5M	4.0%
Q2 25	$5M	4.1%
Q3 25	$5M	3.8%
Q4 25	$5M	3.9%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$855K	$15M
Q2 23	$1M	$14M
Q3 23	$596K	$15M
Q4 23	$445K	$16M
Q1 24	$450K	$16M
Q2 24	$560K	$17M
Q3 24	$412K	$19M
Q4 24	$391K	$23M
Q1 25	$826K	$24M
Q2 25	$1M	$22M
Q3 25	$2M	$23M
Q4 25	$1M	$24M

Revenue Segments

Quarter	ADMA BioManufacturing Segment	Corporate Segment	Plasma Collection Centers Segment
Q1 23	$50M	$36K	$7M
Q2 23	$60M	$36K	$326K
Q3 23	$67M	$36K	$888K
Q1 24	$80M	$36K	$2M
Q2 24	$106M	$36K	$1M
Q3 24	$113M	$36K	$7M
Q4 24	$116M	—	$804K

Revenue by Geography

Quarter	International	United States	Non-US
Q3 23	$3M	$65M	—
Q1 24	$4M	$78M	—
Q2 24	$4M	$103M	—
Q3 24	$5M	$115M	—
Q4 24	$3M	$115M	—
Q1 25	—	$111M	$4M
Q2 25	—	$122M	—
Q3 25	—	$134M	$246K
Q4 25	—	$137M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$69M	$0	$69M
Q2 23	$63M	$0	$63M
Q3 23	$74M	$0	$74M
Q4 23	$51M	$0	$51M
Q1 24	$45M	$0	$45M
Q2 24	$88M	$0	$88M
Q3 24	$87M	$0	$87M
Q4 24	$103M	$0	$103M
Q1 25	$72M	$0	$72M
Q2 25	$90M	$0	$90M
Q3 25	$61M	$0	$61M
Q4 25	$88M	$0	$88M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	222M	+9.4%
Q2 23	223M	+0.3%
Q3 23	234M	+5.0%
Q4 23	226M	-3.3%
Q1 24	236M	+4.6%
Q2 24	242M	+2.4%
Q3 24	245M	+1.1%
Q4 24	246M	+0.4%
Q1 25	245M	-0.5%
Q2 25	249M	+1.6%
Q3 25	245M	-1.6%
Q4 25	244M	-0.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$99K	60
FY 15	$97K	74
FY 16	$116K	92
FY 17	$77K	295
FY 18	$53K	318
FY 19	$93K	314
FY 20	$104K	407
FY 21	$154K	527
FY 22	$250K	617
FY 23	$414K	624
FY 24	$355K	1K
FY 25	$255K	2K